432 related articles for article (PubMed ID: 17038631)
41. Apolipoprotein B secretion and atherosclerosis are decreased in mice with phospholipid-transfer protein deficiency.
Jiang XC; Qin S; Qiao C; Kawano K; Lin M; Skold A; Xiao X; Tall AR
Nat Med; 2001 Jul; 7(7):847-52. PubMed ID: 11433351
[TBL] [Abstract][Full Text] [Related]
42. Berberine promotes the development of atherosclerosis and foam cell formation by inducing scavenger receptor A expression in macrophage.
Li K; Yao W; Zheng X; Liao K
Cell Res; 2009 Aug; 19(8):1006-17. PubMed ID: 19546885
[TBL] [Abstract][Full Text] [Related]
43. Apolipoprotein E promotes the regression of atherosclerosis independently of lowering plasma cholesterol levels.
Raffai RL; Loeb SM; Weisgraber KH
Arterioscler Thromb Vasc Biol; 2005 Feb; 25(2):436-41. PubMed ID: 15591220
[TBL] [Abstract][Full Text] [Related]
44. PPARgamma1-induced caveolin-1 enhances cholesterol efflux and attenuates atherosclerosis in apolipoprotein E-deficient mice.
Hu Q; Zhang XJ; Liu CX; Wang XP; Zhang Y
J Vasc Res; 2010; 47(1):69-79. PubMed ID: 19729954
[TBL] [Abstract][Full Text] [Related]
45. Effect of macrophage ApoE on atherosclerosis in LDL-receptor deficient mice.
Tennert C; Teupser D; Mueller MA; Wilfert W; Renner-Müller I; Stein O; Stein Y; Sippel AE; Wolf E; Thiery J
Biochem Biophys Res Commun; 2007 Sep; 361(3):574-9. PubMed ID: 17669363
[TBL] [Abstract][Full Text] [Related]
46. Atherosclerosis development in apolipoprotein E-null mice deficient for CD69.
Gómez M; Sanz-González SM; Abu Nabah YN; Lamana A; Sánchez-Madrid F; Andrés V
Cardiovasc Res; 2009 Jan; 81(1):197-205. PubMed ID: 18703531
[TBL] [Abstract][Full Text] [Related]
47. Elevation of systemic PLTP, but not macrophage-PLTP, impairs macrophage reverse cholesterol transport in transgenic mice.
Samyn H; Moerland M; van Gent T; van Haperen R; Grosveld F; van Tol A; de Crom R
Atherosclerosis; 2009 Jun; 204(2):429-34. PubMed ID: 19100548
[TBL] [Abstract][Full Text] [Related]
48. Blockade of scavenger receptor class B type I raises high density lipoprotein cholesterol levels but exacerbates atherosclerotic lesion formation in apolipoprotein E deficient mice.
Kitayama K; Nishizawa T; Abe K; Wakabayashi K; Oda T; Inaba T; Amemiya Y
J Pharm Pharmacol; 2006 Dec; 58(12):1629-38. PubMed ID: 17331327
[TBL] [Abstract][Full Text] [Related]
49. Macrophage expression of peroxisome proliferator-activated receptor-alpha reduces atherosclerosis in low-density lipoprotein receptor-deficient mice.
Babaev VR; Ishiguro H; Ding L; Yancey PG; Dove DE; Kovacs WJ; Semenkovich CF; Fazio S; Linton MF
Circulation; 2007 Sep; 116(12):1404-12. PubMed ID: 17724261
[TBL] [Abstract][Full Text] [Related]
50. Deficiency of inducible NO synthase reduces advanced but not early atherosclerosis in apolipoprotein E-deficient mice.
Miyoshi T; Li Y; Shih DM; Wang X; Laubach VE; Matsumoto AH; Helm GA; Lusis AJ; Shi W
Life Sci; 2006 Jul; 79(6):525-31. PubMed ID: 16516241
[TBL] [Abstract][Full Text] [Related]
51. Elimination of platelet factor 4 (PF4) from platelets reduces atherosclerosis in C57Bl/6 and apoE-/- mice.
Sachais BS; Turrentine T; Dawicki McKenna JM; Rux AH; Rader D; Kowalska MA
Thromb Haemost; 2007 Nov; 98(5):1108-13. PubMed ID: 18000617
[TBL] [Abstract][Full Text] [Related]
52. Critical role of macrophage 12/15-lipoxygenase for atherosclerosis in apolipoprotein E-deficient mice.
Huo Y; Zhao L; Hyman MC; Shashkin P; Harry BL; Burcin T; Forlow SB; Stark MA; Smith DF; Clarke S; Srinivasan S; Hedrick CC; Praticò D; Witztum JL; Nadler JL; Funk CD; Ley K
Circulation; 2004 Oct; 110(14):2024-31. PubMed ID: 15451785
[TBL] [Abstract][Full Text] [Related]
53. Serial studies of mouse atherosclerosis by in vivo magnetic resonance imaging detect lesion regression after correction of dyslipidemia.
Trogan E; Fayad ZA; Itskovich VV; Aguinaldo JG; Mani V; Fallon JT; Chereshnev I; Fisher EA
Arterioscler Thromb Vasc Biol; 2004 Sep; 24(9):1714-9. PubMed ID: 15256400
[TBL] [Abstract][Full Text] [Related]
54. Angiotensin II amplifies macrophage-driven atherosclerosis.
Nobuhiko A; Suganuma E; Babaev VR; Fogo A; Swift LL; Linton MF; Fazio S; Ichikawa I; Kon V
Arterioscler Thromb Vasc Biol; 2004 Nov; 24(11):2143-8. PubMed ID: 15374850
[TBL] [Abstract][Full Text] [Related]
55. The long-term effect of angiotensin II type 1a receptor deficiency on hypercholesterolemia-induced atherosclerosis.
Eto H; Miyata M; Shirasawa T; Akasaki Y; Hamada N; Nagaki A; Orihara K; Biro S; Tei C
Hypertens Res; 2008 Aug; 31(8):1631-42. PubMed ID: 18971539
[TBL] [Abstract][Full Text] [Related]
56. Endothelial overexpression of Fas ligand decreases atherosclerosis in apolipoprotein E-deficient mice.
Yang J; Sato K; Aprahamian T; Brown NJ; Hutcheson J; Bialik A; Perlman H; Walsh K
Arterioscler Thromb Vasc Biol; 2004 Aug; 24(8):1466-73. PubMed ID: 15178561
[TBL] [Abstract][Full Text] [Related]
57. Remodelling of the zero-stress state and residual strains in apoE-deficient mouse aorta.
Gregersen H; Zhao J; Lu X; Zhou J; Falk E
Biorheology; 2007; 44(2):75-89. PubMed ID: 17538200
[TBL] [Abstract][Full Text] [Related]
58. Critical role of macrophages in glucocorticoid driven vascular calcification in a mouse-model of atherosclerosis.
Preusch MR; Rattazzi M; Albrecht C; Merle U; Tuckermann J; Schütz G; Blessing E; Zoppellaro G; Pauletto P; Krempien R; Rosenfeld ME; Katus HA; Bea F
Arterioscler Thromb Vasc Biol; 2008 Dec; 28(12):2158-64. PubMed ID: 18787189
[TBL] [Abstract][Full Text] [Related]
59. Elevated expression of phospholipid transfer protein in bone marrow derived cells causes atherosclerosis.
van Haperen R; Samyn H; Moerland M; van Gent T; Peeters M; Grosveld F; van Tol A; de Crom R
PLoS One; 2008 May; 3(5):e2255. PubMed ID: 18509527
[TBL] [Abstract][Full Text] [Related]
60. Connexin37 protects against atherosclerosis by regulating monocyte adhesion.
Wong CW; Christen T; Roth I; Chadjichristos CE; Derouette JP; Foglia BF; Chanson M; Goodenough DA; Kwak BR
Nat Med; 2006 Aug; 12(8):950-4. PubMed ID: 16862155
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
